We narrowed to 307 results for: GAI

...directly by creating well characterised antibodies against all human extracellular proteins with community-based...

...blocked, it is stained with a primary antibody against your protein of interest. But which antibody should...

...of whole phages as therapeutics, which is also gaining a lot of new traction lately (1, 2), depends on...

...DNA ligase, are naturally able to discriminate against ligating substrates containing base pair mismatches...

...and Red (ReNL; plasmid #85203) NLuc fusions. The Nagai lab has additionally deposited more than 25 fusions...

...multiplicity of infection (MOI=ratio of virus to cells). Again, my tip here is to test several protocols as the...

...temperature allows the repressor to re-nature and again repress expression of exo, beta and gam.  A major...

...signal in these assays (Dempster et al., 2019). Again, the experimental strategy is clear: for any gene...

...modifications, and other factors that AAV utilizes to gain entry into the cell (Dudek, AM. 2018).  If the serotype...

...mutagenesis screens that detect loss-of-function or gain-of-function mutations. In these screens, the transposons...

...principles of this classification system will help you gain a deeper appreciation and understanding of CRISPR...

...briefly go through each section of this article again. In the beginning, we talked about the relationship...

...complexes - from the cell-lysate using antibodies against the target protein. The captured protein complexes...

...lymphocytes from the bone marrow to the thymus where they gain their specificity or from the thymus to the lymph...

...in any NIH grant application! Using FRET, you may gain a new structural understanding of your protein that...

...for sufficient opsin to reach the axon terminal. Again, this must be empirically determined in your own...

...precise location. The end of the heteroduplex rests against the RuvC nuclease domain, which stabilizes the ...

...pick one or the other. Which prime editor is which again? We’re glad you asked. Hopefully this table helps...

...succeed. With respect to de novo sgRNA design, I again separate it into two categories. On the one hand...

...used to protect the RNAs from cellular defenses against ssRNA: phosphatase treatment, substituting cytidine...